IP Library Granted Patent US 11,219,208
Granted Patent B2
US 11,219,208 · App. 16/687,336 · Granted Jan 11, 2022

High osmolarity antimicrobial composition containing one or more organic solvents

Inventor: Matthew F. Myntti (St. Augustine, FL)
Assignee: Next Science IP Holdings Pty Ltd
A01N25/02A01N31/02A01N33/12A01N37/02A01N37/40A01N41/10A61K8/33A61K8/34A61K8/39A61K8/416A61K8/463A61Q17/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,219,208
App. No.
16/687,336
Granted
Jan 11, 2022
Kind
B2
Abstract

A composition that can solvate biofilms and disrupt bacterial cell walls acts to both kill the bacteria by cell lysis and remove the biofilm. This solvent-containing composition is effective against a broad spectrum of microbes and can be used on a variety of surfaces, both living and inanimate. The polarity of the solvent component of the composition is lower than that of pure water so that the composition exhibits increased efficacy in solvating the macromolecular matrix of a biofilm and in penetrating bacterial cell walls.

Claims (29)

1. A method for rinsing a surgical site, said method comprising introducing to said site a liquid composition that consists of

(1) a solvent component exhibiting a δ p value of from 13.7 to 15.4 MPa 1/2 that consists of water and one or more C 1 -C 16 acyclic alcohols; and

(2) a solute component that comprises cationic surfactant, dissociation products of at least one monoprotic organic acid, and dissociation products of at least one salt of at least one monoprotic organic acid,

said composition having a pH of greater than about 3 but less than 5.0 and an effective solute concentration of from 1 to 2.33 Osm/L.

2. The method of claim 1 wherein said composition exhibits a pH of less than 4.6.

3. The method of claim 2 wherein said composition exhibits a pH of less than 4.4.

4. The method of claim 3 wherein said composition exhibits a pH of less than 4.2.

5. The method of claim 1 wherein said one or more C 1 -C 16 acyclic alcohols of said composition comprises ethanol.

6. The method of claim 5 wherein said one or more C 1 -C 16 acyclic alcohols is ethanol.

7. The method of claim 1 wherein said at least one monoprotic organic acid of said composition comprises acetic acid.

8. The method of claim 7 wherein said at least one monoprotic organic acid is acetic acid.

9. The method of claim 7 wherein said at least one salt of at least one monoprotic organic acid comprises an acetate.

10. The method of claim 9 wherein said at least one salt of at least one monoprotic organic acid is an acetate.

11. The method of claim 1 wherein said composition has an effective solute concentration of at least 1.5 Osm/L.

12. The method of claim 11 wherein said composition has an effective solute concentration of at least 1.75 Osm/L.

13. A process for reducing microbial contamination during surgery, said process comprising introducing to a surgical site a liquid wash composition that consists of

(1) a solvent component exhibiting a δ p value of from 13.7 to 15.4 MPa 1/2 that consists of water and ethanol; and

(2) a solute component that consists of cationic surfactant, dissociation products of a monoprotic organic acid, and dissociation products of a salt of a monoprotic organic acid,

said composition having a pH of greater than about 3 but less than 4.4 and an effective solute concentration of from 1 to 2.33 Osm/L.

14. The process of claim 13 wherein said monoprotic organic acid of said composition is acetic acid.

15. The process of claim 14 wherein said salt of a monoprotic organic acid is an acetate.

16. The process of claim 13 wherein said composition has an effective solute concentration of at least 1.5 Osm/L.

17. The process of claim 16 wherein said composition has an effective solute concentration of at least 1.75 Osm/L.

18. A process for reducing microbial contamination during surgery, said process comprising introducing to a surgical site a liquid wash composition that consists of

(1) a solvent component exhibiting a δ p value of from 13.7 to 15.4 MPa 1/2 that consists of water and ethanol; and

(2) a solute component that consists of cationic surfactant, dissociation products of acetic acid, and dissociation products of a salt of a monoprotic organic acid,

said composition having a pH of greater than about 3 but less than 4.4 and an effective solute concentration of at least 1.5 Osm/L.

19. The process of claim 18 wherein said salt of a monoprotic organic acid is an acetate.

20. The process of claim 18 wherein said composition has an effective solute concentration of at least 1.75 Osm/L.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2025
From: NEXT SCIENCE IP HOLDINGS PTY LTD
To: OSARTIS GMBH
Reel/Frame 072590/0763 →
Continuity (5)
Continuation 15976806 · May 10, 2018
Continuation 14888437
Provisional Application 61818586 · May 2, 2013
Provisional Application 61873500 · Sep 4, 2013
Related Publication 20200085038A1 · Mar 19, 2020